NicOx S.A.
Nicox S.A., together with its subsidiaries, operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve eye health. The company's lead product candidate is NCX 470, a novel nitric oxide (NO)-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in P… Read more
NicOx S.A. (ALCOX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2023: 0.000x
Based on the latest financial reports, NicOx S.A. (ALCOX) has a cash flow conversion efficiency ratio of 0.000x as of December 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€8.32K) by net assets (€21.41 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NicOx S.A. - Cash Flow Conversion Efficiency Trend (2020–2022)
This chart illustrates how NicOx S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
NicOx S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NicOx S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EcoFirst Consolidated Bhd
KLSE:3557
|
0.008x |
|
PVP Ventures Limited
NSE:PVP
|
0.006x |
|
AB Traction
ST:TRAC-B
|
0.030x |
|
Tier1 Technology S.A.
MC:TR1
|
0.106x |
|
JMC Electronics Co Ltd
TW:6552
|
0.030x |
|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
-0.480x |
|
ACHILLES THERAP.SP.ADS/1
F:698
|
N/A |
|
Broncus Holding Corporation
PINK:BRNHF
|
-0.029x |
Annual Cash Flow Conversion Efficiency for NicOx S.A. (2020–2022)
The table below shows the annual cash flow conversion efficiency of NicOx S.A. from 2020 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €59.61 Million | €-23.12 Million | -0.388x | -58.58% |
| 2021-12-31 | €75.55 Million | €-18.48 Million | -0.245x | -357.45% |
| 2020-12-31 | €100.83 Million | €-5.39 Million | -0.053x | -- |